NVCR
14.33 USD
+1.65%
Today
+5.66%
1D
Market is closed
Sun
Closed
Mon
4:30 PM ~ 10:59 PM
Tue
4:30 PM ~ 10:59 PM
Wed
4:30 PM ~ 10:59 PM
Thu
4:30 PM ~ 10:59 PM
Fri
4:30 PM ~ 10:59 PM
Sat
Closed
Information
Name
NovoCure Limited
Currency
USD
Market Cap
1.57B
Avg Daily Volume
1.44M
52 Week High
21.451 USD
52 Week Low
9.82 USD
Trading Hours
See hours
Business Summary
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Germany, France, Japan, Greater China, and internationally. Its TTFields devices include Optune Gio, Optune Lua, and Optune Pax. The company also has ongoing clinical trials investigating TTFields in brain metastases, gastric cancer, glioblastoma, liver cancer, non-small cell lung cancer, pancreatic cancer, and ovarian cancer. NovoCure Limited was incorporated in 2000 and is headquartered in Baar, Switzerland.
Top News
NovoCure
+6.98%
NovoCure: 3 Key Takeaways for Long-Term Investors
finance.yahoo.com
2d ago
NovoCure
+6.98%
NovoCure Limited Stock 12‑Month Price Target Cut to $21.33, Implies 62% Upside
tradingview.com
3d ago
NovoCure
+6.98%
NovoCure (NVCR) Q3 Results Spark Margin Turn Debate
finance.yahoo.com
4d ago
Show more
Frequently Asked Questions
What are healthcare stocks and why are they important to investors?
Healthcare stocks include pharmaceutical companies, biotech firms, hospitals, and medical device manufacturers.
Are healthcare stocks less volatile?
Generally yes. Because healthcare is a necessity, demand remains relatively steady, making the sector less sensitive to economic cycles.
What drives growth in healthcare investments?
Aging populations, technological advancements, and increased healthcare spending contribute to long-term growth in the sector.
What are the risks of investing in healthcare?
Regulatory changes, drug approval delays, and legal challenges can affect the profitability and stock prices of healthcare companies.
